BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 220721)

  • 1. [Use of Celestene by ionization in the treatment of rheumatic diseases].
    Aaron C; Quesnel MJ
    Sem Hop; 1978 Oct 18-25; 54(33-36):1091-4. PubMed ID: 220721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of an immunodepressive treatment in La Peyronie's disease, Dupuytren's disease and certain sclerodermas].
    Sturm M; Lebeuf M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):523-5. PubMed ID: 5152896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)].
    Hasche-Klünder R
    Urologe A; 1978 Jul; 17(4):224-7. PubMed ID: 308273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocopherols in treatment of primary fibrositis; including Dupuytren's contracture, periarthritis of the shoulders, and Peyronie's disease.
    STEINBERG CL
    AMA Arch Surg; 1951 Dec; 63(6):824-33. PubMed ID: 14868250
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of vascular allergids with Peyronie's and Dupuytren's disease. Favorable therapeutic effects of delta-butazolidine].
    TEODORESCO S; BADANOIU A
    Bull Soc Fr Dermatol Syphiligr; 1962; 69():295-300. PubMed ID: 13980590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proglumetacin: a flexible and broad-spectrum antirheumatic agent].
    Fontanesi G; Giancecchi F; Rotini R; Tartaglia I
    Minerva Med; 1983 Jun; 74(26):1547-51. PubMed ID: 6602308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of Peyronie's disease associated with degenerative rheumatic signs].
    Ağbaba S; Yenal O
    Tip Fak Mecm; 1969; 32(3):460-73. PubMed ID: 5398999
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty.
    Wang CX; Flick TR; Patel AH; Sanchez F; Sherman WF
    Knee; 2021 Mar; 29():190-200. PubMed ID: 33640618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flufenamic acid in rheumatology].
    Cabanel G; Phélip X; Verdier JM
    J Med Lyon; 1970 Oct; 51(195):1771-2 passim. PubMed ID: 5317350
    [No Abstract]   [Full Text] [Related]  

  • 10. [New therapy for Peyronie's disease: superoxide dismutase by ionization. Comparison with an earlier classical series].
    Vergès J; Chateau A
    Ann Urol (Paris); 1988; 22(2):143-4. PubMed ID: 3382163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-statistical study on the anti-inflammatory activity of proglumetacin. Proglumetacin: at last a complete anti-inflammatory agent?].
    Benvenuti M; Albanese L; Pagliara L
    Minerva Med; 1983 Jun; 74(26):1563-8. PubMed ID: 6602310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of betamethasone phosphate in local injections].
    Exertier J
    Lyon Med; 1965 Oct; 214(40):495-8. PubMed ID: 5295300
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iontophoresis in Peyronie's disease. Our experience].
    Pérez Espejo Mde L; Campoy Martínez P; Pérez Pérez M; Argüelles Salido E; Rodríguez Pérez A; Soltero González A
    Arch Esp Urol; 2003 Dec; 56(10):1133-7. PubMed ID: 14763419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the treatment of chronic rheumatic diseases with orthoxyquinoline sulfonate of dimethyl-amino-phenazone].
    Alberto S; Brusasco L; Colongo PG
    Minerva Med; 1967 Mar; 58(18 Suppl):762-6. PubMed ID: 5297789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short-term study of proglumetacin].
    Zanoli S; Pace N; Raffaelli P
    Minerva Med; 1983 Jun; 74(26):1543-5. PubMed ID: 6222271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyronie's disease associated with Dupuytren's contracture.
    WALLER JI; DREESE WC
    J Urol; 1952 Sep; 68(3):623-5. PubMed ID: 12991360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peyronie's disease and peripheral neuropathies].
    Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A
    Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic efficacy and tolerance of a new drug, sodium diclofenac, in inflammatory and metabolic rheumatism].
    Nicoletti B; Mignemi G
    Minerva Med; 1978 Oct; 69(48):3293-7. PubMed ID: 310087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.